down arrow

Phreesia, Inc.

  • Market Cap: Small Cap
  • Industry: Software Products
  • ISIN: US71944F1066
USD
12.59
-0.24 (-1.87%)

Feb 05

NYS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

12.4712.94

52 Week

12.2132.76
Valuation
Technical
Day's Volume

CASH

406.88 k

Shareholding (Oct 2025)

FII

16.86%

Held by 114 FIIs

DII

36.78%

Held by 52 DIIs

Promoter

1.86%

How big is Phreesia, Inc.?

22-Jun-2025

As of Jun 18, Phreesia, Inc. has a market capitalization of $1.52 billion, with net sales of $434.53 million and a net loss of $42.71 million over the latest four quarters. Shareholder's funds are $264.81 million, and total assets amount to $388.53 million.

As of Jun 18, Phreesia, Inc. has a market capitalization of 1,522.57 million, classifying it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 434.53 million for the latest four quarters, while the net profit for the same period was a loss of 42.71 million.<BR><BR>As of Jan 25, the reporting period shows that Phreesia, Inc. has shareholder's funds amounting to 264.81 million and total assets of 388.53 million.

View full answer

What does Phreesia, Inc. do?

22-Jun-2025

Phreesia, Inc. is a U.S.-based healthcare software company specializing in patient intake and payment solutions, with recent net sales of $116 million and a market cap of approximately $1.52 billion. The company reported a net loss of $4 million and has a negative return on equity of -16.06%.

Overview:<BR>Phreesia, Inc. is a United States-based healthcare software company that provides a suite of applications for managing the patient intake process and payment solutions, operating within the Software Products industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 116 Million (Quarterly Results - Apr 2025) <BR>Most recent Net Profit: -4 Million (Quarterly Results - Apr 2025) <BR>Market-cap: USD 1,522.57 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.29 <BR>Return on Equity: -16.06% <BR>Price to Book: 5.40<BR><BR>Contact Details:<BR>Address: 434 FAYETTEVILLE ST., SUITE 1400, RALEIGH NC : 27601 <BR>Tel: 1 646 7479959 <BR>Fax: 1 646 6071776 <BR>Website: https://www.phreesia.com

View full answer

Who are in the management team of Phreesia, Inc.?

22-Jun-2025

As of March 2022, the management team of Phreesia, Inc. includes CEO Chaim Indig, Independent Chairman Michael Weintraub, and directors Lainie Goldstein, Dusty Lieb, Edward Cahill, Gillian Munson, and Cheryl Pegus. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Phreesia, Inc. includes the following individuals:<BR><BR>- Mr. Michael Weintraub, Independent Chairman of the Board<BR>- Mr. Chaim Indig, Chief Executive Officer and Director<BR>- Ms. Lainie Goldstein, Director<BR>- Mr. Dusty Lieb, Director<BR>- Mr. Edward Cahill, Independent Director<BR>- Ms. Gillian Munson, Independent Director<BR>- Dr. Cheryl Pegus, Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and overseeing its operations.

View full answer

Is Phreesia, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Phreesia, Inc. shows a mildly bearish technical trend with underperformance against the S&P 500, reflecting weakness in multiple indicators.

As of 31 October 2025, the technical trend for Phreesia, Inc. has changed from bearish to mildly bearish. The weekly MACD and moving averages are bearish, while the monthly MACD is also bearish. The Bollinger Bands indicate a mildly bearish stance in both weekly and monthly time frames. The KST shows a bearish signal weekly but bullish monthly, while Dow Theory indicates a mildly bearish trend weekly with no trend monthly. <BR><BR>In terms of performance, Phreesia has underperformed the S&P 500 across multiple periods, with a year-to-date return of -10.41% compared to the S&P 500's 16.30%, and a 5-year return of -41.07% versus 109.18% for the index. Overall, the technical stance is mildly bearish, reflecting weakness across several indicators.

View full answer

Compare Phreesia, Inc. with Similar Stocks

Magnite, Inc.Zuora, Inc.Genius Sports Ltd.
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

With a growth in Net Sales of 14.83%, the company declared Very Positive results in Jul 25

  • The company has declared positive results for the last 5 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 51.69 MM
  • ROCE(HY) Highest at -8.76%
  • NET SALES(Q) Highest at USD 117.25 MM
2

High Institutional Holdings at 100%

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Software Products

stock-summary
Market cap

USD 936 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.31

stock-summary
Return on Equity

-1.96%

stock-summary
Price to Book

2.92

Revenue and Profits:
Net Sales:
120 Million
(Quarterly Results - Oct 2025)
Net Profit:
4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-44.46%
0%
-44.46%
6 Months
-53.54%
0%
-53.54%
1 Year
-56.59%
0%
-56.59%
2 Years
-51.45%
0%
-51.45%
3 Years
-66.75%
0%
-66.75%
4 Years
-57.67%
0%
-57.67%
5 Years
-83.11%
0%
-83.11%

Phreesia, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Phreesia Stock Hits Day Low of $15.41 Amid Price Pressure

Phreesia Stock Hits Day Low of $15.41 Amid Price Pressure

Phreesia, Inc. experienced significant stock volatility on December 9, 2025, with a notable decline. The company has faced considerable long-term challenges, including substantial year-to-date and multi-year drops. However, it reported a 14.83% growth in net sales recently, indicating some operational resilience amidst ongoing difficulties.

Read full news article
Phreesia, Inc. Stock Plummets to New 52-Week Low of $15.41

Phreesia, Inc. Stock Plummets to New 52-Week Low of $15.41

Phreesia, Inc., a small-cap software company, has reached a new 52-week low, reflecting a 23.04% decline over the past year, contrasting with the S&P 500's positive performance. With a market cap of USD 1,609 million, the company faces challenges in profitability and operates with a unique financial structure.

Read full news article

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
27.39%
EBIT Growth (5y)
-11.07%
EBIT to Interest (avg)
-67.85
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
1.42
Tax Ratio
7.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.67
EV to EBIT
-36.19
EV to EBITDA
-125.10
EV to Capital Employed
7.54
EV to Sales
3.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.84%
ROE (Latest)
-16.06%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Oct 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 75 Schemes (44.03%)

Foreign Institutions

Held by 114 Foreign Institutions (16.86%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Oct'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Oct 2025 is 12.64% vs 16.59% in Oct 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Oct 2025 is 129.86% vs 54.86% in Oct 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Oct'25",
        "Oct'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120.30",
          "val2": "106.80",
          "chgp": "12.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.30",
          "val2": "-5.40",
          "chgp": "346.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.60",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.30",
          "val2": "-14.40",
          "chgp": "129.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.50%",
          "val2": "-129.60%",
          "chgp": "17.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jan'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jan 2025 is 17.82% vs 26.84% in Jan 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jan 2025 is 57.27% vs 22.26% in Jan 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jan'25",
        "Jan'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "419.80",
          "val2": "356.30",
          "chgp": "17.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-25.30",
          "val2": "-102.80",
          "chgp": "75.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "1.90",
          "chgp": "21.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-4.20",
          "chgp": "80.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-58.50",
          "val2": "-136.90",
          "chgp": "57.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-131.00%",
          "val2": "-374.30%",
          "chgp": "24.33%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Oct'25 - YoYstock-summary

Oct'25
Oct'24
Change(%)
Net Sales
120.30
106.80
12.64%
Operating Profit (PBDIT) excl Other Income
13.30
-5.40
346.30%
Interest
0.30
0.60
-50.00%
Exceptional Items
-2.00
0.00
Consolidate Net Profit
4.30
-14.40
129.86%
Operating Profit Margin (Excl OI)
47.50%
-129.60%
17.71%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Oct 2025 is 12.64% vs 16.59% in Oct 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Oct 2025 is 129.86% vs 54.86% in Oct 2024

All Quarterly Resultsstock-summary

Annual Results Snapshot (Consolidated) - Jan'25stock-summary

Jan'25
Jan'24
Change(%)
Net Sales
419.80
356.30
17.82%
Operating Profit (PBDIT) excl Other Income
-25.30
-102.80
75.39%
Interest
2.30
1.90
21.05%
Exceptional Items
-0.80
-4.20
80.95%
Consolidate Net Profit
-58.50
-136.90
57.27%
Operating Profit Margin (Excl OI)
-131.00%
-374.30%
24.33%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Jan 2025 is 17.82% vs 26.84% in Jan 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jan 2025 is 57.27% vs 22.26% in Jan 2024

All Annual Resultsstock-summary
stock-summaryCompany CV
About Phreesia, Inc. stock-summary
stock-summary
Phreesia, Inc.
Software Products
Phreesia, Inc. is a United States-based healthcare software company. The Company provides healthcare organizations a suite of applications to manage the patient intake process and payment solution for patient payments. The Company provides software as a service platform which enables organizations to capture patient records and engage with patients. The Company’s software products enable appointments, registration, revenue cycle, patient surveys, patient activation, analytics and reports, and integration.
Company Coordinates stock-summary
Company Details
434 FAYETTEVILLE ST., SUITE 1400 , RALEIGH NC : 27601
stock-summary
Tel: 1 646 7479959
stock-summary
https://www.phreesia.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."